You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Preimplantation Genetics Diagnosis (PGD) Market Professional Research Report 2021-2027

Market Analysis and Insights: Global Preimplantation Genetics Diagnosis (PGD) Market
The research report studies the Preimplantation Genetics Diagnosis (PGD) market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Preimplantation Genetics Diagnosis (PGD) market size is projected to reach US$ 127.4 million by 2027, from US$ 97 million in 2020, at a CAGR of 3.5% during 2021-2027.
Global Preimplantation Genetics Diagnosis (PGD) Scope and Segment
The global Preimplantation Genetics Diagnosis (PGD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preimplantation Genetics Diagnosis (PGD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Gender Selection
Chromosomal Abnormalities
Single Gene Disorders
HLA Typing
X-Linked Diseases
by Application, this report covers the following segments
Global Preimplantation Genetics Diagnosis (PGD) market: regional analysis, the major regions covered in the report are:
North America
United States
Rest of Europe
South Korea
Southeast Asia
Rest of Asia-Pacific
Latin America
Middle East & Africa
Saudi Arabia
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Preimplantation Genetics Diagnosis (PGD) key players in this market include:
Abbott Laboratories
Natera, Inc
F. Hoffmann-La Roche
Thermo Fisher Scientific
Laboratory Corporation of America Holdings
Agilent Technologies
Quest Diagnostics Incorporated
Cooper Surgical
Beijing Genomics Institute (BGI)
Genea Limited
1 Market Overview of Preimplantation Genetics Diagnosis (PGD)
1.1 Preimplantation Genetics Diagnosis (PGD) Market Overview
1.1.1 Preimplantation Genetics Diagnosis (PGD) Product Scope
1.1.2 Preimplantation Genetics Diagnosis (PGD) Market Status and Outlook
1.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2016-2027)
1.4 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Region (2016-2021)
1.5 Global Preimplantation Genetics Diagnosis (PGD) Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Preimplantation Genetics Diagnosis (PGD) Market Size (2016-2027)
1.6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size (2016-2027)
1.6.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size (2016-2027)
1.6.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size (2016-2027)
1.6.4 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size (2016-2027)
1.6.5 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size (2016-2027)

2 Preimplantation Genetics Diagnosis (PGD) Market Overview by Type
2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Type (2016-2021)
2.3 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2022-2027)
2.4 Gender Selection
2.5 Chromosomal Abnormalities
2.6 Single Gene Disorders
2.7 HLA Typing
2.8 Aneuploidy
2.9 X-Linked Diseases
2.10 Others

3 Preimplantation Genetics Diagnosis (PGD) Market Overview by Application
3.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Application (2016-2021)
3.3 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2022-2027)
3.4 Hospitals
3.5 Clinics
3.6 Others

4 Preimplantation Genetics Diagnosis (PGD) Competition Analysis by Players
4.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2020)
4.3 Date of Key Players Enter into Preimplantation Genetics Diagnosis (PGD) Market
4.4 Global Top Players Preimplantation Genetics Diagnosis (PGD) Headquarters and Area Served
4.5 Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
4.6 Competitive Status
4.6.1 Preimplantation Genetics Diagnosis (PGD) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.1.4 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2016-2021)
5.1.5 Abbott Laboratories Recent Developments
5.2 Natera, Inc
5.2.1 Natera, Inc Profile
5.2.2 Natera, Inc Main Business
5.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.2.4 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2016-2021)
5.2.5 Natera, Inc Recent Developments
5.3 PerkinElmer
5.3.1 PerkinElmer Profile
5.3.2 PerkinElmer Main Business
5.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.3.4 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2016-2021)
5.3.5 Illumina Recent Developments
5.4 Illumina
5.4.1 Illumina Profile
5.4.2 Illumina Main Business
5.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.4.4 Illumina Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2016-2021)
5.4.5 Illumina Recent Developments
5.5 F. Hoffmann-La Roche
5.5.1 F. Hoffmann-La Roche Profile
5.5.2 F. Hoffmann-La Roche Main Business
5.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2016-2021)
5.5.5 F. Hoffmann-La Roche Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2016-2021)
5.6.5 Thermo Fisher Scientific Recent Developments
5.7 Laboratory Corporation of America Holdings
5.7.1 Laboratory Corporation of America Holdings Profile
5.7.2 Laboratory Corporation of America Holdings Main Business
5.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.7.4 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2016-2021)
5.7.5 Laboratory Corporation of America Holdings Recent Developments
5.8 Agilent Technologies
5.8.1 Agilent Technologies Profile
5.8.2 Agilent Technologies Main Business
5.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.8.4 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2016-2021)
5.8.5 Agilent Technologies Recent Developments
5.9 Quest Diagnostics Incorporated
5.9.1 Quest Diagnostics Incorporated Profile
5.9.2 Quest Diagnostics Incorporated Main Business
5.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.9.4 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2016-2021)
5.9.5 Quest Diagnostics Incorporated Recent Developments
5.10 Cooper Surgical
5.10.1 Cooper Surgical Profile
5.10.2 Cooper Surgical Main Business
5.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.10.4 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2016-2021)
5.10.5 Cooper Surgical Recent Developments
5.11 Beijing Genomics Institute (BGI)
5.11.1 Beijing Genomics Institute (BGI) Profile
5.11.2 Beijing Genomics Institute (BGI) Main Business
5.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.11.4 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2016-2021)
5.11.5 Beijing Genomics Institute (BGI) Recent Developments
5.12 Genea Limited
5.12.1 Genea Limited Profile
5.12.2 Genea Limited Main Business
5.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Products, Services and Solutions
5.12.4 Genea Limited Preimplantation Genetics Diagnosis (PGD) Revenue (US$ Million) & (2016-2021)
5.12.5 Genea Limited Recent Developments

6 North America
6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2016-2027)
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 Preimplantation Genetics Diagnosis (PGD) Market Dynamics
11.1 Preimplantation Genetics Diagnosis (PGD) Industry Trends
11.2 Preimplantation Genetics Diagnosis (PGD) Market Drivers
11.3 Preimplantation Genetics Diagnosis (PGD) Market Challenges
11.4 Preimplantation Genetics Diagnosis (PGD) Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
  • PUBLISHED DATE: May, 2021
  • NO OF PAGES: 125